High Probability of Long-term Survival in 2-year Survivors of Autologous Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in First or Second Complete Remission


We describe the long-term outcomes of autologous hematopoietic cell transplantation (HCT) for 315 AML patients in first or second complete remission (CR). All patients were in continuous CR for ⩾2 years after HCT. Patients were predominantly transplanted in CR1 (78%) and had good or intermediate cytogenetic risk disease (74%). Median follow-up of survivors… (More)
DOI: 10.1038/bmt.2010.115


6 Figures and Tables

Slides referencing similar topics